Northern Trust’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Sell |
123,636
-8,409
| -6% | -$841K | ﹤0.01% | 1973 |
|
|
2025
Q4 | $12.8M | Sell |
132,045
-5,454
| -4% | -$468K | ﹤0.01% | 1945 |
|
|
2025
Q3 | $9.78M | Sell |
137,499
-5,729
| -4% | -$382K | ﹤0.01% | 2118 |
|
|
2025
Q2 | $8.56M | Sell |
143,228
-16,132
| -10% | -$884K | ﹤0.01% | 2158 |
|
|
2025
Q1 | $8.36M | Buy |
159,360
+16,291
| +11% | +$915K | ﹤0.01% | 2142 |
|
|
2024
Q4 | $7.87M | Buy |
143,069
+9,722
| +7% | +$512K | ﹤0.01% | 2263 |
|
|
2024
Q3 | $6.71M | Buy |
133,347
+7,461
| +6% | +$344K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $5.53M | Buy |
125,886
+1,256
| +1% | +$53.4K | ﹤0.01% | 2339 |
|
|
2024
Q1 | $5.48M | Buy |
124,630
+39,026
| +46% | +$1.72M | ﹤0.01% | 2391 |
|
|
2023
Q4 | $4.06M | Buy |
85,604
+2,101
| +3% | +$88.3K | ﹤0.01% | 2623 |
|
|
2023
Q3 | $3.71M | Buy |
83,503
+3,830
| +5% | +$178K | ﹤0.01% | 2615 |
|
|
2023
Q2 | $3.8M | Buy |
79,673
+995
| +1% | +$44.9K | ﹤0.01% | 2651 |
|
|
2023
Q1 | $3.1M | Buy |
78,678
+608
| +0.8% | +$22.1K | ﹤0.01% | 2734 |
|
|
2022
Q4 | $2.21M | Buy |
78,070
+367
| +0.5% | +$10.5K | ﹤0.01% | 2950 |
|
|
2022
Q3 | $2.34M | Sell |
77,703
-162
| -0.2% | -$5.64K | ﹤0.01% | 2934 |
|
|
2022
Q2 | $2.64M | Buy |
77,865
+3,855
| +5% | +$138K | ﹤0.01% | 2905 |
|
|
2022
Q1 | $3.32M | Sell |
74,010
-2,865
| -4% | -$132K | ﹤0.01% | 2824 |
|
|
2021
Q4 | $3.55M | Sell |
76,875
-2,847
| -4% | -$115K | ﹤0.01% | 2908 |
|
|
2021
Q3 | $2.68M | Sell |
79,722
-188
| -0.2% | -$6.39K | ﹤0.01% | 3125 |
|
|
2021
Q2 | $2.35M | Sell |
79,910
-1,994
| -2% | -$54.9K | ﹤0.01% | 3280 |
|
|
2021
Q1 | $2.11M | Sell |
81,904
-17,256
| -17% | -$412K | ﹤0.01% | 3212 |
|
|
2020
Q4 | $2.26M | Sell |
99,160
-6,249
| -6% | -$144K | ﹤0.01% | 3138 |
|
|
2020
Q3 | $2.25M | Sell |
105,409
-2,276
| -2% | -$51.1K | ﹤0.01% | 3004 |
|
|
2020
Q2 | $2.5M | Buy |
107,685
+10,710
| +11% | +$230K | ﹤0.01% | 2915 |
|
|
2020
Q1 | $2.07M | Buy |
96,975
+7,675
| +9% | +$183K | ﹤0.01% | 2836 |
|
|
2019
Q4 | $2.09M | Buy |
89,300
+282
| +0.3% | +$6.59K | ﹤0.01% | 3113 |
|
|
2019
Q3 | $1.87M | Buy |
89,018
+15,722
| +21% | +$321K | ﹤0.01% | 3138 |
|
|
2019
Q2 | $1.5M | Buy |
73,296
+1,765
| +2% | +$41.6K | ﹤0.01% | 3208 |
|
|
2019
Q1 | $2.01M | Buy |
71,531
+417
| +0.6% | +$10.9K | ﹤0.01% | 3084 |
|
|
2018
Q4 | $1.74M | Sell |
71,114
-454
| -0.6% | -$12.2K | ﹤0.01% | 3128 |
|
|
2018
Q3 | $2.66M | Buy |
71,568
+12,791
| +22% | +$345K | ﹤0.01% | 3066 |
|
|
2018
Q2 | $1.22M | Buy |
58,777
+31,986
| +119% | +$565K | ﹤0.01% | 3408 |
|
|
2018
Q1 | $386K | Buy |
26,791
+5,850
| +28% | +$83.3K | ﹤0.01% | 3638 |
|
|
2017
Q4 | $318K | Buy |
20,941
+44
| +0.2% | +$559 | ﹤0.01% | 3669 |
|
|
2017
Q3 | $201K | Sell |
20,897
-210
| -1% | -$1.99K | ﹤0.01% | 3799 |
|
|
2017
Q2 | $181K | Sell |
21,107
-35,410
| -63% | -$302K | ﹤0.01% | 3823 |
|
|
2017
Q1 | $503K | Sell |
56,517
-12,365
| -18% | -$115K | ﹤0.01% | 3538 |
|
|
2016
Q4 | $765K | Buy |
68,882
+4,330
| +7% | +$46.6K | ﹤0.01% | 3419 |
|
|
2016
Q3 | $1.1M | Sell |
64,552
-1,911
| -3% | -$35.4K | ﹤0.01% | 3318 |
|
|
2016
Q2 | $1.45M | Buy |
66,463
+22,932
| +53% | +$413K | ﹤0.01% | 3200 |
|
|
2016
Q1 | $834K | Buy |
43,531
+1,675
| +4% | +$32.1K | ﹤0.01% | 3313 |
|
|
2015
Q4 | $1.17M | Buy |
41,856
+12,516
| +43% | +$354K | ﹤0.01% | 3269 |
|
|
2015
Q3 | $715K | Buy |
+29,340
| New | +$702K | ﹤0.01% | 3402 |
|
Other funds holding IRMD
CCM
VCM
NTCM
Northern Trust's IRMD Position: Q1 2026 in Review
Northern Trust reduced its iRadimed (IRMD) stake by 6.4% in Q1 2026, selling an estimated $841K and leaving 123,636 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1973.
Northern Trust first reported a position in IRMD in Q3 2015 and has held it in 43 quarters since. The position peaked at $12.8M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Northern Trust held 123,636 shares of iRadimed worth $11.9M as of Q1 2026.
- Northern Trust sold 8,409 iRadimed shares in Q1 2026, an estimated $841K.
- iRadimed made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1973 holding.
- Northern Trust first reported a position in iRadimed in Q3 2015 and has held it in 43 quarters since.
- Northern Trust's iRadimed position peaked at $12.8M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.